- Home
- BBT vs QURE Comparison
BBT vs QURE Comparison
Compare BBT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBT
- QURE
- Stock Information
- Founded
- BBT 1846
- QURE 1998
- Country
- BBT United States
- QURE Netherlands
- Employees
- BBT N/A
- QURE N/A
- Industry
- BBT Banks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- BBT Finance
- QURE Health Care
- Exchange
- BBT Nasdaq
- QURE Nasdaq
- Market Cap
- BBT 2.0B
- QURE 1.9B
- IPO Year
- BBT N/A
- QURE 2007
- Fundamental
- Price
- BBT $25.94
- QURE $27.71
- Analyst Decision
- BBT Buy
- QURE Strong Buy
- Analyst Count
- BBT 2
- QURE 13
- Target Price
- BBT $33.00
- QURE $62.33
- AVG Volume (30 Days)
- BBT 1.1M
- QURE 4.7M
- Earning Date
- BBT 10-29-2025
- QURE 11-10-2025
- Dividend Yield
- BBT 1.25%
- QURE N/A
- EPS Growth
- BBT N/A
- QURE N/A
- EPS
- BBT 0.09
- QURE N/A
- Revenue
- BBT $318,120,000.00
- QURE $15,751,000.00
- Revenue This Year
- BBT $63.25
- QURE N/A
- Revenue Next Year
- BBT $64.02
- QURE $229.18
- P/E Ratio
- BBT $272.57
- QURE N/A
- Revenue Growth
- BBT N/A
- QURE N/A
- 52 Week Low
- BBT $22.27
- QURE $5.85
- 52 Week High
- BBT $30.50
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- BBT N/A
- QURE 34.01
- Support Level
- BBT N/A
- QURE $26.20
- Resistance Level
- BBT N/A
- QURE $29.99
- Average True Range (ATR)
- BBT 0.00
- QURE 2.87
- MACD
- BBT 0.00
- QURE -0.32
- Stochastic Oscillator
- BBT 0.00
- QURE 39.98
About BBT Beacon Financial Corporation Common stock
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.